Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
Abstract

Volume 26, Issue 3 (May 2024) 26, 239–244; 10.4103/aja202381

Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index

Gian Maria Busetto1,2, Bernarde F Rodrigues3, Ashraf Virmani4, Andrea Checchia1,5, Antonella Ninivaggi1,2, Anna Ricapito1,2, Giovanni Barbieri1,2, Piero Fischetti1,2, Ugo G Falagario1, Pasquale Annese2, Nicola d’Altilia2, Vito Mancini2, Matteo Ferro6, Felice Crocetto7, Angelo Porreca8, Carlo Bettocchi1,2, Luigi Cormio1,9, Ashok Agarwal10, Giuseppe Carrieri1,2

1University of Foggia, Foggia 71122, Italy; 2Department of Urology and Renal Transplantation, Policlinico of Foggia, Foggia 71122, Italy; 3Department of Urology, Human Reproduction Section, Federal University of Sao Paulo, Sao Paulo 05403-000, Brazil; 4Alfasigma Healthscience, Utrecht 3528 BG, The Netherlands; 5Urology Unit, “G. Tatarella” Hospital, Cerignola 71042, Italy; 6Urology Unit, European Institute of Oncology (IEO) IRCCS, Milan 20142, Italy; 7University of Naples Federico II, Naples 80126, Italy; 8Department of Oncological Urology, Veneto Institute of Oncology (IOV) IRCCS, Padua 35039, Italy; 9Urology Unit, “L. Bonomo” Hospital, Andria 70031, Italy; 10Global Andrology Forum, Moreland Hills, OH 44022, USA.

Correspondence: Gian Maria Busetto

Received: 11 October 2023; Accepted: 03 December 2023; published online: 02 February 2024

Abstract

Oxidative stress is one of the main mechanisms responsible for male infertility. Various conditions such as varicocele, obesity, advanced age, and lifestyle can lead to an increase in reactive oxygen species, causing an oxidative imbalance in the reproductive environment. Spermatozoa are sensitive to reactive oxygen species and require energy to carry out their main function of fertilizing the egg. Excessive reactive oxygen species can affect sperm metabolism, leading to immobility, impaired acrosome reaction, and cell death, thereby impairing reproductive success. This double-blind randomized study evaluated the effect of supplementation with L-carnitine, acetyl-L-carnitine, vitamins, and other nutrients on semen quality in 104 infertile patients with or without varicocele, while also investigating the impact of factors such as obesity and advanced age on treatment. Sperm concentration significantly increased in the supplemented group compared to the placebo group (P = 0.0186). Total sperm count also significantly increased in the supplemented group (P = 0.0117), as did sperm motility (P = 0.0120). The treatment had a positive effect on patients up to 35 years of age in terms of sperm concentration (P = 0.0352), while a body mass index (BMI) above 25 kg m−2 had a negative effect on sperm concentration (P = 0.0110). Results were not showing a net benefit in stratifying patients in accordance with their BMI since sperm quality increase was not affected by this parameter. In conclusion, antioxidant supplementation may be beneficial for infertile patients and has a more positive effect on younger patients with a normal weight.

Full Text | PDF |

 
Browse:  194
 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.